Best Peptide Protocols
    Recovery / HealingSingle

    BPC-157 30mg / 30mL Nasal Spray: Dosage & Research Protocol Guide

    Dosing ranges, administration details, cycle length, and storage guidance for BPC-157 (Spray) 30 mg / 30 ml.

    Strength & Form:5 mg Vial10 mg Vial30 mg / 30 ml Spray250 mcg / 60 ct Capsules
    BPC-157 (Spray) 30 mg / 30 ml peptide vial

    BPC-157 (Spray) 30 mg / 30 ml

    30 mg / 30 ml Research Peptide

    Shop on ResearchLabs

    Quick Facts

    Type
    Single
    Category
    Recovery / Healing
    Vial Strength
    30 mg / 30 ml
    Status
    Research

    Research Purposes Only

    This information is provided for educational purposes only. This content is not intended to diagnose, treat, cure, or prevent any disease. Always consult with qualified healthcare professionals.

    Download Guide

    Save the complete BPC-157 30mg / 30mL Nasal Spray research guide as a PDF.

    Educational and research use only. Not medical advice.

    Reference

    Sources used for this guide are listed in our research database .

    What Is BPC-157 30mg / 30mL Nasal Spray?

    BPC-157 30mg / 30mL Nasal Spray Nasal Spray Overview

    BPC-157 Nasal Spray delivers the body protection compound via intranasal administration for rapid systemic absorption. The 30 mg / 30 ml format provides approximately 1 mg per ml, enabling precise nasal dosing without injection. Research suggests intranasal delivery may offer faster onset due to the rich vasculature of the nasal mucosa, with direct access to the CNS via the olfactory pathway.

    BPC-157 30mg / 30mL Nasal Spray Quick Reference

    BPC-157 30mg / 30mL Nasal Spray Nasal Spray Specifications

    Peptide
    BPC-157 (Spray) 30 mg / 30 ml (NNMT inhibitor)
    Vial Content
    30 mg BPC-157 in 30 ml nasal spray
    Category
    Recovery / Healing
    Administration Method
    Intranasal spray
    Common Use Case
    Non-invasive BPC-157 delivery for recovery and gut-brain axis research

    BPC-157 30mg / 30mL Nasal Spray Compared With Other Formats

    Details that distinguish this 30 mg / 30 ml format include:

    • No injection required
    • Rapid absorption via nasal mucosa
    • Direct CNS access via olfactory pathway
    • Convenient daily dosing

    How Does BPC-157 Work?

    BPC-157 Mechanism of Action

    BPC-157 delivered intranasally crosses the nasal epithelium into systemic circulation and may access the CNS directly via the olfactory nerve. It modulates nitric oxide, upregulates growth factors, and promotes angiogenesis.

    What Are the Potential Benefits of BPC-157?

    BPC-157 Research Findings and Observed Outcomes

    Findings and reported areas of study for BPC-157 (Spray) 30 mg / 30 ml include:

    • Non-invasive tissue repair support
    • Gut-brain axis modulation
    • Rapid systemic absorption
    • CNS-accessible delivery route

    These observations are discussed for research and educational reference only and are not medical claims.

    What Do You Need to Use BPC-157 30mg / 30mL Nasal Spray?

    BPC-157 30mg / 30mL Nasal Spray Supplies for Use and Handling

    • •BPC-157 Nasal Spray bottle

    Supplies listed are for laboratory handling and research preparation purposes only.

    BPC-157 30mg / 30mL Nasal Spray Administration and Research Protocol

    BPC-157 Nasal Route, Frequency and Timing

    RouteIntranasal
    Frequency2x daily
    TimingMorning and evening, on an empty stomach

    Alternate nostrils. Tilt head slightly forward.

    BPC-157 30mg / 30mL Nasal Spray Dosage Guide

    BPC-157 Dosage Ranges

    The ranges below pair the listed dose with the draw volume for this product strength.

    Low Range1 spray (100 mcg) 2x/day
    Standard Range2 sprays (200 mcg) 2x/day
    Upper Range3 sprays (300 mcg) 2x/day

    BPC-157 30mg / 30mL Nasal Spray Dosage Examples

    Based on reconstitution below

    Target Daily DoseDraw VolumeUnits
    100 mcg1 sprayPer nostril
    200 mcg2 spraysPer nostril
    300 mcg3 spraysPer nostril

    This dosing table is unique to the 30 mg / 30 ml vial. Units refer to markings on a standard U-100 insulin syringe (1 unit = 0.01 mL).

    How Long Does BPC-157 30mg / 30mL Nasal Spray Last?

    BPC-157 30mg / 30mL Nasal Spray Duration by Research Dose

    At common research doses, one 30 mg / 30 ml vial of BPC-157 typically supports:

    1 spray (100 mcg) 2x/day4–8 weeks
    2 sprays (200 mcg) 2x/day4–6 weeks
    3 sprays (300 mcg) 2x/day4 weeks

    Recovery and gut health research

    BPC-157 30mg / 30mL Nasal Spray Preparation and Handling

    BPC-157 30mg / 30mL Nasal Spray Use and Handling Instructions

    This section applies specifically to the BPC-157 (Spray) 30 mg / 30 ml.

    Recommended Diluent
    Pre-mixed
    Diluent Volume
    30 ml
    Final Concentration
    1 mg/ml

    BPC-157 30mg / 30mL Nasal Spray Preparation Steps

    1. 1Remove the vial from storage and allow it to reach room temperature (10–15 minutes).
    2. 2Wash hands thoroughly and prepare a clean workspace with all supplies.
    3. 3Using a sterile syringe, draw the appropriate volume of bacteriostatic water.
    4. 4Clean the rubber stopper of the vial with an alcohol prep pad.
    5. 5Insert the needle at a slight angle and slowly inject the diluent down the inner wall of the vial.
    6. 6Gently swirl or roll the vial until fully dissolved; the solution should appear clear and colorless.
    7. 7Label the vial with reconstitution date and refrigerate at 2–8 °C (35.6–46.4 °F), protected from light. Use within 2–4 weeks.

    BPC-157 Stacks and Research Combinations

    BPC-157 and Compatible Research Pairings

    In research settings, BPC-157 (Spray) 30 mg / 30 ml is sometimes paired with peptides such as:

    Factors That May Affect BPC-157 Research Outcomes

    Supporting Factors for BPC-157 Research

    Factors recorded alongside this protocol include:

    • Clear nasal passages before use
    • Avoid blowing nose for 5 min after
    • Store refrigerated

    These factors can affect how research observations are interpreted.

    BPC-157 Side Effects and Safety Considerations

    BPC-157 30mg / 30mL Nasal Spray Tolerability Notes

    Very well-tolerated intranasally

    Some individuals report:

    • Mild nasal irritation
    • Transient taste in throat

    How to Store BPC-157 Before and After Opening

    BPC-157 30mg / 30mL Nasal Spray Storage Requirements

    Unreconstituted
    N/A — pre-mixed
    Reconstituted
    Refrigerate (2–8°C) after opening
    Post-Mix Stability
    Use within 30 days of opening

    Who Should Avoid BPC-157?

    This peptide is generally not recommended for:

    • Those with active nasal infections
    • Pregnant or breastfeeding individuals

    BPC-157 30mg / 30mL Nasal Spray FAQs

    How many doses per bottle?

    Approximately 150 sprays per 30 ml bottle at ~0.1 ml per spray.

    Can I use this with injectable BPC-157?

    Yes, nasal and injectable routes can complement each other for different research targets.

    Where to Buy BPC-157 30mg / 30mL Nasal Spray for Research

    BPC-157 30mg / 30mL Nasal Spray Purchasing and Research Supply Notes

    Before ordering BPC-157 (Spray) 30 mg / 30 ml, review the product label, available testing documents, and storage instructions.

    Check the ResearchLabs listing for:

    • Available testing documents
    • Product strength and concentration
    • Storage and handling instructions
    • Current product availability

    View the current listing for BPC-157 (Spray) 30 mg / 30 ml:

    → View on ResearchLabs

    Confirm the product strength and storage requirements before ordering. Products are for laboratory research only and are not for human consumption.

    Related Recovery / Healing Peptides

    ARA-290 (16 mg Vial) productARA-290 (16 mg Vial)BPC-157 (5 mg Vial) productBPC-157 (5 mg Vial)BPC-157 (10 mg Vial) productBPC-157 (10 mg Vial)Cartalax (25 mg Vial) productCartalax (25 mg Vial)KPV (10 mg Vial) productKPV (10 mg Vial)LL-37 (5 mg Vial) productLL-37 (5 mg Vial)